# Finerenone and Semaglutide now on team kidney

Page: https://stenobird.com/podcast/for-kidneys-sake-7026065/finerenone-and-semaglutide-now-on-team-kidney
Text version: https://stenobird.com/podcast/for-kidneys-sake-7026065/finerenone-and-semaglutide-now-on-team-kidney.md
Podcast: [For Kidneys Sake](https://stenobird.com/podcast/for-kidneys-sake-7026065)
Published: 2026-02-10T01:00:00+00:00
Episode link: https://www.buzzsprout.com/2404938/episodes/18639764-finerenone-and-semaglutide-now-on-team-kidney.mp3
Audio file: https://www.buzzsprout.com/2404938/episodes/18639764-finerenone-and-semaglutide-now-on-team-kidney.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/for-kidneys-sake-7026065/episodes/finerenone-and-semaglutide-now-on-team-kidney
Duration seconds: 1118

## Resource

Do you have a question? Send it now... The For Kidneys Sake podcast series is brought to you by Imperial College Healthcare NHS Trust and North West London Integrated Care Board (NWL NHS) For years, diabetic kidney disease felt frustratingly static: ACE inhibitors, ARBs… and then very little else. In this episode, Porf Jeremy Levy and Dr Andrew Frankel unpack why that era is finally over. With SGLT2 inhibitors already changing practice, attention now turns to two newer players finerenon...

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/for-kidneys-sake-7026065/episodes/finerenone-and-semaglutide-now-on-team-kidney/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/for-kidneys-sake-7026065/finerenone-and-semaglutide-now-on-team-kidney.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.